VSee Health, Inc. (VSEE)
USD 1.06
(-2.75%)
USD 1.06
(-2.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 5.84 Million | 6.37 Million | 7.33 Million | 6.8 Million |
| Cost of Revenue | 1.93 Million | 1.54 Million | 1.41 Million | 1.34 Million |
| Gross Profit | 3.9 Million | 4.83 Million | 5.92 Million | 5.46 Million |
| Operating Expenses | 5.28 Million | 3.59 Million | 282.67 Thousand | 5.05 Million |
| Selling, General and Administrative Expenses | 5.37 Million | 3.59 Million | 282.67 Thousand | 5.05 Million |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | - | 156.51 Thousand | 986.00 | - |
| Cost and Expenses | 7.22 Million | 3.59 Million | 282.67 Thousand | 6.4 Million |
| Operating Income | -1.47 Million | -3.59 Million | -282.67 Thousand | 404.49 Thousand |
| Interest Expense | 2.17 Million | 31.86 Thousand | - | - |
| Income Tax Expense | 1.83 Million | 187.22 Thousand | 108.11 Thousand | 100.59 Thousand |
| Earnings before Tax | -1.57 Million | -3.05 Million | -280.7 Thousand | 359.47 Thousand |
| Net Income | -3.44 Million | -3.24 Million | -280.7 Thousand | 258.87 Thousand |
| Earnings Per Share Basic | -0.44 | -0.25 | -0.02 | 0.03 |
| Earnings Per Share Diluted | -0.44 | -0.25 | -0.02 | 0.03 |
| Weighted Average Shares Outstanding | 9.99 Million | 12.74 Million | 14.93 Million | 9.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.99 Million | 12.74 Million | 14.93 Million | 9.84 Million |
| Gross Margin | 0.67 | 0.76 | 0.81 | 0.80 |
| EBIT Margin | -0.38 | -0.56 | -0.04 | -0.01 |
| Profit Margin | -0.59 | -0.51 | -0.04 | 0.04 |
| EBITDA | -2.23 Million | -1.58 Million | -282.67 Thousand | -45.02 Thousand |
| Earnings Before Tax Margin | -0.25 | -0.56 | -0.04 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.71 Million | 1.49 Million | 5.84 Million | 1.5 Million | 1.45 Million | - |
| Cost of Revenue | 486.64 Thousand | 386.25 Thousand | 1.93 Million | 405.18 Thousand | 478.39 Thousand | - |
| Gross Profit | 1.22 Million | 1.1 Million | 3.9 Million | 1.09 Million | 973.07 Thousand | - |
| Operating Expenses | 1.42 Million | 674.26 Thousand | 2.59 Million | 925.66 Thousand | 518.08 Thousand | 442.42 Thousand |
| Selling, General and Administrative Expenses | 1.42 Million | 674.26 Thousand | - | 925.66 Thousand | 518.08 Thousand | 442.42 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2.00 | - | - | - | - | - |
| Cost and Expenses | 1.91 Million | 674.26 Thousand | 2.59 Million | 925.66 Thousand | 518.08 Thousand | 442.42 Thousand |
| Operating Income | -1.18 Million | -674.26 Thousand | -2.59 Million | -925.66 Thousand | -518.08 Thousand | -442.43 Thousand |
| Interest Expense | 349.69 Thousand | 134.28 Thousand | 2.17 Million | 1.69 Million | 184.5 Thousand | 164.54 Thousand |
| Income Tax Expense | -2.24 Million | -618.00 | 1.83 Million | 2.42 Million | 233.71 Thousand | - |
| Earnings before Tax | -2.6 Million | -967.81 Thousand | -4.41 Million | -2.86 Million | 78.28 Thousand | 263.55 Thousand |
| Net Income | -329.98 Thousand | -967.81 Thousand | -4.41 Million | -2.86 Million | 78.28 Thousand | 263.55 Thousand |
| Earnings Per Share Basic | -0.06 | -0.27 | - | -0.71 | 0.02 | 0.06 |
| Earnings Per Share Diluted | -0.06 | -0.27 | - | -0.71 | 0.02 | 0.06 |
| Weighted Average Shares Outstanding | 5.3 Million | 3.6 Million | 4.09 Million | 4.05 Million | 4.18 Million | 4.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.3 Million | 3.6 Million | 4.09 Million | 4.05 Million | 4.18 Million | 4.18 Million |
| Gross Margin | 0.72 | 0.74 | 0.67 | 0.73 | 0.67 | - |
| EBIT Margin | -0.12 | -0.45 | - | -0.62 | -0.36 | - |
| Profit Margin | -0.19 | -0.65 | -0.76 | -1.90 | 0.05 | - |
| EBITDA | -202.53 Thousand | -674.26 Thousand | - | -925.66 Thousand | -518.08 Thousand | -442.43 Thousand |
| Earnings Before Tax Margin | -0.69 | -0.45 | -0.44 | -0.62 | -0.36 | - |
IDKOY
GVR
FFXDF
MALEE
FEMY
ZVSA